Skiplink Navigation

Main Features

Novartis to invest $500 million in Russia

Swiss pharmaceutical company Novartis says it plans to invest $500 million (SFr483 million) in Russia over a five-year period.

Novartis says the investment will include the construction of a drug production plant in the western city of St Petersburg as well as research and development partnerships with local companies.

The Basel-based company says construction of the plant starts in 2011. It will be used to produce 1.5 billion generic and proprietary drugs each year when completed.

Novartis says the investment is one of the biggest it has ever made in local manufacturing.

Shares in the company rose 0.4 per cent to SFr56.95 ($58.85) on the Zurich exchange during early trading on Monday. and agencies


Neuer Inhalt

Horizontal Line

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!